Your browser doesn't support javascript.
loading
Corrigendum to 'Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults'. [Vaccine 36 (2018) 6325-6333].
Brandon, Donald; Kimmel, Murray; Kuriyakose, Sherine O; Kostanyan, Lusiné; Mesaros, Narcisa.
Afiliación
  • Brandon D; California Research Foundation, 4180 Ruffin Road, San Diego, 92123 CA, United States. Electronic address: dbrandon@crftrials.com.
  • Kimmel M; Accelovance, Suite 102, 1600 West Eau Gallie Blvd, Melbourne, FL, United States. Electronic address: mkimmel@optimalsites.net.
  • Kuriyakose SO; GSK, 5 Embassy Links, Cunningham Road, 560052 Bangalore, India. Electronic address: sherine.o.kuriyakose@gsk.com.
  • Kostanyan L; XPE Pharma & Science, 19A Avenue Edison, 1300 Wavre, Belgium c/o GSK, Belgium. Electronic address: lusine.x.kostanyan@gsk.com.
  • Mesaros N; GSK, 20 Avenue Fleming, 1300 Wavre, Belgium. Electronic address: narcisa.x.mesaros@gsk.com.
Vaccine ; 38(12): 2746-2747, 2020 Mar 10.
Article en En | MEDLINE | ID: mdl-32061383
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos